You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -8.2% | -1.5% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -16.7 | 0.0 |
PEG | 0.0 | 1.9 |
Price / Revenue | 1.9 | 1.4 |
Price / Book value | 1.5 |
Latest | Forecast | |
---|---|---|
Revenue | 23.9% | 17.4% |
PBT | 0.0% | n/a |
EPS | 0.0% | -113.8% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 11.62 | -8.88 | -0.70p | -9.3 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 13.03 | -7.66 | -0.60p | -1.7 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 16.47 | -13.15 | $0.00 | -2.6 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 19.75 | -5.14 | $0.00 | -10.3 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 24.48 | -2.83 | $0.00 | -17.1 | 0.0 | n/a | n/a | 0.0% |
Tissue Regenix signs exclusive distribution deal in China Sharecast News | 18 Jan |
---|---|
Tissue Regenix strikes distribution deal in Italy Sharecast News | 09 Mar |
Final results for the year ended 31 December 2022 | 21-Mar-23 14:50 |
---|---|
Notice of results and Investor presentation | 06-Mar-23 15:04 |
Trading update for 2022 | 31-Jan-23 14:46 |
Change of Adviser | 31-Jan-23 14:44 |
Holding(s) in Company | 18-Jan-23 18:17 |